Cat Stace, Executive Vice President of Business Development

Cat holds an MSci in Biochemistry (Nottingham), PhD Cell Biology (Cambridge), and a MBA (Open University).

Cat has 18 years experience in the drug discovery industry, specialising in biotechnology platforms and commercialisation. She has held strategic technology and business development roles in biotechnology, consultancy and CRO organisations, covering small molecule therapeutics, peptides, healthtech and engineering.

Prior to Kuano, Cat was EVP Business Development for Domainex, during which the business more than doubled in size. Cat began her career establishing therapeutic platforms and discovery programmes for Isogenica and Bicycle Therapeutics, becoming inventor of core industrial technology and clinical candidates.

Cat’s primary objective is to bring in revenue streams to Kuano through collaborations and partnerships.